The discovery of CCR3/H1 dual antagonists with reduced hERG risk

A structural basis for drug-induced long QT syndrome

John S. Mitcheson, Jun Chen, Monica Lin et al. · Proceedings of the National Academy of Sciences · 2000 · 929 citations · Full text

Cardiac Muscle, Channelopathies, Cardiomyopathy +11

Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT

Matt Bridgland-Taylor, Alee Hargreaves, Alison Easter et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 150 citations

Electrophysiological Evaluation, Engineering, Analytical Instrumentation +8

Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration

John R. White, Judithann M. Lee, Kimberly Dede et al. · Journal of Biological Chemistry · 2000 · 121 citations · Full text

Metal‐catalysed isotopic exchange labelling: 30 years of experience in pharmaceutical R&D

Paul Allen, Michael Hickey, Lee Kingston et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2010 · 95 citations

Isotopic Exchange Labelling, Medicinal Chemistry, Engineering +13

Comparative Pharmacology of Guinea Pig Cardiac Myocyte and Cloned hERG (I_Kr) Channel

Christina Savanthi. Davie, JEAN PIERRE‐VALENTIN, Chris Pollard et al. · Journal of Cardiovascular Electrophysiology · 2004 · 69 citations